Stryker Corporation

US$325.87As of Sun 8 Nov 2026, 12:00 UTC
NYSE:SYKHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.15%
Div yield 1.08%
ROE 16.02%
Medical Devices
Beta (5Y) 0.78
PE TTM 34.70
TSR TTM (7.51%)
Mkt cap US$124.1B
ROIC 12.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$408
25.35%
(82.75%)
Hold 7|4|7|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
8.69
9.07
9.07
8.90
24.22%
28.34%
20.65%
13.91%
Revenue$B
7.989
8.378
8.416
8.811
9.09%
14.89%
11.39%
11.07%
Peers (US$124.1B)
Cap (US$)
PE
190.4B
40.88x
61.96B
18.05x
124.6B
25.08x
Capital
TTM
5Y
10Y
Leveragex
0.959
0.448
0.342
EBIT/Intx
1.281
0.242
0.244
Own earn%
(6.13)
47.78
54.82
Sh yield%
43.72
31.37
33.14
Owners
Insiders/Inst%
4.87
53.58
Short interest%
5.97
SBC / revenue%
4.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–17
$1 testx
—
Incr. ROIC%
3

Stryker Corporation is a medical technology company operating through MedSurg and Neurotechnology, and Orthopaedics segments, offering surgical, navigation, emergency, stroke treatment and orthobiologic products, plus joint replacement and trauma implants and Mako Shoulder robotics. It sells to doctors, hospitals and other healthcare facilities via subsidiaries, branches and third-party distributors in about 61 countries.